StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

LeonaBio's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.93M. For fiscal 2025 it was -$45.73M. The highest annual figure on record is -$3.71M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$45.73M–
FY2024Dec 31, 2024-$97.17M–
FY2023Dec 31, 2023-$100.75M–
FY2022Dec 31, 2022-$72.47M–
FY2021Dec 31, 2021-$43.10M–
FY2020Dec 31, 2020-$24.11M–
FY2019Dec 31, 2019-$3.71M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$16.96M–
Q1 FY2026Mar 31, 2026-$20.90M–
Q4 FY2025Dec 31, 2025-$19.40M–
Q3 FY2025Sep 30, 2025-$4.67M–
Q2 FY2025Jun 30, 2025-$7.00M–
Q1 FY2025Mar 31, 2025-$14.67M–
Q4 FY2024Dec 31, 2024-$26.01M–
Q3 FY2024Sep 30, 2024-$23.02M–
Q2 FY2024Jun 30, 2024-$22.33M–
Q1 FY2024Mar 31, 2024-$25.80M–
Q4 FY2023Dec 31, 2023-$26.29M–
Q3 FY2023Sep 30, 2023-$23.98M–
Q2 FY2023Jun 30, 2023-$24.28M–
Q1 FY2023Mar 31, 2023-$26.19M–
Q4 FY2022Dec 31, 2022-$15.67M–
Q3 FY2022Sep 30, 2022-$21.64M–
Q2 FY2022Jun 30, 2022-$18.59M–
Q1 FY2022Mar 31, 2022-$16.57M–
Q4 FY2021Dec 31, 2021-$18.18M–
Q3 FY2021Sep 30, 2021-$10.30M–
Q2 FY2021Jun 30, 2021-$7.32M–
Q1 FY2021Mar 31, 2021-$7.31M–
Q4 FY2020Dec 31, 2020-$10.67M–
Q3 FY2020Sep 30, 2020-$9.41M–
Q2 FY2020Jun 30, 2020-$2.86M–
Q1 FY2020Mar 31, 2020-$1.18M–
Q4 FY2019Dec 31, 2019-$1.03M–

More LeonaBio figures

See a number that looks wrong?